By STS Capital
We often hear the phrase “crisis creates opportunity.” While it may sound cliché, it’s becoming a very real truth for U.S.-based consumer goods companies. As global dynamics shift – driven by tariffs, trade tensions, and supply chain constraints – the definition of value in M&A is evolving. What used to be seen as basic operational capacity is now being recast as strategic infrastructure.
A recent Wall Street Journal article revealed that Procter & Gamble is actively reviewing the possibility of localizing more of its production in the U.S., including changes to ingredient sourcing and even reformulating products to reduce exposure to imported components. Multinationals are increasingly looking to localize production and reduce tariff exposure.
This shift is reshaping the M&A landscape, especially benefiting U.S. companies with assets that have gone from standard to strategic.
Table of Contents
- The New Strategic Asset
- Beyond Consumer Goods
- What It Means for U.S. Business Owners
- The Smart Moves in an Upside-Down World
The New Strategic Asset
1. U.S.-Based Manufacturing Capacity
According to the Reshoring Initiative, a record 364,000 jobs were reshored to the U.S. in 2022, continuing a 12-year upward trend. Sectors seeing the highest reshoring activity include food manufacturing, health products, and household goods. For companies with FDA-registered facilities or USDA compliance, interest from global buyers is intensifying. If you have scalable capacity or can onboard third-party production, you’re positioned as a strategic partner in the new global playbook.
2. Domestic Ingredient and Raw Material Suppliers
In food, health, and beauty, ingredients and packaging materials are frequently the pinch points. Suppliers who source, process, or package domestically (especially with certifications like USDA Organic, Non-GMO, or FDA/GRAS) have become more than vendors. IBISWorld notes that domestic essential oil and botanical manufacturers are experiencing consistent growth, fueled by increased demand from CPG brands localizing inputs for compliance and reliability.
3. Private Label and Contract Manufacturers
What was once a commoditized segment is now experiencing renewed interest. A 2024 Deloitte survey noted a surge in global brands outsourcing production to U.S.-based third parties, seeking flexible, compliant, and scalable partners.
Contract manufacturers with certifications and flexibility are seeing increased demand.
4. Underutilized Production Assets
Facilities with excess capacity – especially those that are FDA-compliant, food-grade, or pharma-ready – are attractive entry points for foreign buyers seeking speed-to-market advantages.
PwC notes that industrial buyers are increasingly prioritizing infrastructure access over greenfield development. Companies with ready-made capacity offer a shortcut to tariff mitigation and local market presence.
Beyond Consumer Goods
While this article focuses on consumer goods, these dynamics are not confined to CPG. Industrial manufacturing, healthcare products, electronics, and even agriculture are experiencing similar pressures.
Any industry dependent on compliant sourcing, complex logistics, or regulatory oversight is seeing value shift from scale and efficiency toward proximity, compliance, and resilience. Companies that once relied on overseas suppliers are actively seeking domestic partners or acquisition targets to de-risk operations.
What It Means for U.S. Business Owners
For many mid-market U.S. companies – especially those with domestic production, regulatory strengths, or reliable sourcing – now is the moment to reassess your strategic position.
While overall M&A activity has softened due to uncertainty and rising rates, strategic buyers are increasingly focused on assets that offer proximity, compliance, and operational resilience. The full value of these capabilities hasn’t yet been reflected in valuations, but that may soon change.
Consider:
- A full or partial sale while strategic interest is rising
- Joint ventures with global brands looking to localize
- Capital investment to scale domestic capabilities ahead of demand
The companies that prepare now will be best positioned to benefit when market confidence returns and value catches up with strategic importance.
The Smart Moves in an Upside-Down World
Trade tensions, tariffs, and regulatory upheaval may seem like macroeconomic threats. But for certain U.S.-based businesses, they mark a turning point, a rare convergence of strategic value and buyer urgency.
This is a moment to ask:
- Is now the time to explore an exit while valuations are strong?
- Could a joint venture or strategic partnership unlock accelerated growth?
- How can your business be positioned not just as a producer, but as a solution to global risk?
“The M&A landscape is changing, and not because the fundamentals are broken, but because the rules of risk and reward are changing. Companies that once competed on price or scale are now competing on proximity, resilience, and compliance. If you’re a U.S. business owner with domestic operations, now is not the time to operate quietly. This could be the time to assess, position, and, if the timing is right and act. Strategic value is on the move.” Mauro Schnaidman, STS Managing Director
STS Capital Partners is the expert guides for entrepreneurial business owners on the journey to achieving Extraordinary Exits™. By selling your business strategically to the people that buy strategically, you can achieve maximum multiples, create legacy potential and realize true potential value. Contact us if you are ready to explore what your opportunity could look like.